1. Atkinson W, Wolfe S, Hamborsky J, Mclntyre L. Epidemiology and Prevention of Vaccine-prevenable Disease. 11th ed. Washington DC: Public Health Foundation, 2009.
2. Lee EJ, Kwon SY, Seo TH, et al. Clinical features of acute hepatitis A in recent two years. Korean J Gastroenterol 2008;52:298–303.
3. Jung YK, Kim JH. Epidemiology and clinical features of acute hepatitis A: from the domestic perspective. Korean J Hepatol 2009;15:438–445.
4. Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992;10(Suppl 1):S56–S58.
5. Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 1992;10(Suppl 1):S15–S17.
6. Lee KY, Song KH, Kang JH. Seroepidemiology of hepatitis A in Taejon, Korea 1996. J Korean Pediatr Soc 1998;41:53–61.
7. Song KS, Kim JH, Kim YS, et al. Investigation about atypical clinical courses inpatients with acute viral hepatitis A [Abstract]. Korean J Hepatol 2006;12(Suppl 3):S80.
8. Song YB, Lee JH, Choi MS, et al. The age-specific seroprevalence of hepatitis A virus antibody in Korea. Korean J Hepatol 2007;13:27–33.
9. Byun KS, Kim JH, Song KJ, et al. Molecular epidemiology of hepatitis A virus in Korea. J Gastroenterol Hepatol 2001;16:519–524.
10. Yun H, Kim S, Lee H, et al. Genetic analysis of HAV strains isolated from patients with acute hepatitis in Korea, 2005-2006. J Med Virol 2008;80:777–784.
11. Yoon YK, Chun BC, Lee HK, et al. Epidemiological and genetic analysis of a sustained community-wide outbreak of hepatitis A in the republic of Korea, 2008: a hospital-based case-control study. J Clin Virol 2009;46:184–188.
12. Robert P. Hepatitis B. In: Mark F, Lawrence SF, Lawrence JB, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/management. 9th ed. vol. 2. Philadelphia: Saunders, 2009:1287–1309.
13. Jacqueline GO, Gary LD. Hepatitis C. In: Mark F, Lawrence SF, Lawrence JB, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/management 9th ed. Philadelphia: Saunders; 2009;1313–1336.
15. Choi BY. Changing patterns of hepatitis A virus infection in Korea. Korean J Med 2008;75(Suppl 2):S656–S660.
16. Maria HS, Joseph GC. Hepatitis A. In: Mark F, Lawrence SF, Lawrence JB, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/management 9th ed. Philadelphia: Saunders; 2009;1279–1285.
17. Robertson BH, Jansen RW, Khanna B, et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 1992;73:1365–1377.
19. Kim JS, Kim SH. Molecular epidemiology of an outbreak of hepatitis A in Korea. Korean J Clin Pathol 2001;21:114–118.
20. Park JY, Lee JB, Jeong SY, Lee SH, Lee MA, Choi HJ. Molecular characterization of an acute hepatitis A outbreak among healthcare workers at a Korean hospital. J Hosp Infect 2007;67:175–181.
21. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992;10(Suppl 1):S59–S62.
22. Kim TW, Lee KJ. Antibody to hepatitis A antigen in children and adolescents in Korea. J Korean Pediatr Soc 1982;25:36–40.
23. Roh HO, Sohn YM, Park MS, et al. A seroepidemiologic study of hepatitis A virus in healthy children and adolescent in Kyonggi-do province. Korean J Pediatr Infect Dis 1997;4:232–239.
24. Han SH, Lee SH, Roh BJ, et al. An outbreak of hepatitis A in South Korean military personnel: a clinical and epidemiologic study. Korean J Hepatol 2001;7:392–400.
25. Kim NJ, Sung JK, Lee SW, et al. An outbreak of hepatitis A in Taejeon city. Korean J Gastroenterol 1999;34:205–212.
26. Lee KO, Jeong SJ, Seong HS, et al. Genetic analysis of hepatitis A virus isolated from Korea. J Bacteriol Virol 2009;39:165–171.
27. Hollinger FB, Khan NC, Oefinger PE, et al. Posttransfusion hepatitis type A. JAMA 1983;250:2313–2317.
28. Bradley DW, Maynard JE, Hindman SH, et al. Serodiagnosis of viral hepatitis A: detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay. J Clin Microbiol 1977;5:521–530.
29. Liaw YF, Yang CY, Chu CM, Huang MJ. Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak. Infection 1986;14:156–158.
30. Burke DS, Graham RR, Heisey GB. Hepatitis A virus in primates outside captivity. Lancet 1981;2:928–929.
31. Yotsuyanagi H, Iino S, Koike K, Yasuda K, Hino K, Kurokawa K. Duration of viremia in human hepatitis A viral infection as determined by polymerase chain reaction. J Med Virol 1993;40:35–38.
32. Kim HS, Kim HS, Lee JY, et al. Initial thrombocytopenia as a simple, valuable predictor for clinical manifestation in acute hepatitis A. Scand J Gastroenterol 2008;43:81–88.
33. Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007;357:1685–1694.
34. Clemens R, Safary A, Hepburn A, Roche C, Stanbury WJ, André FE. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995;171(Suppl 1):S44–S49.